New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
08:51 EDTTEARTearLab price target lowered to $11 from $15 at Roth Capital
Roth Capital reduced its price target on TearLab after the company made a negative preannouncement and provided lower than expected initial 2014 revenue guidance. But the firm keeps a Buy rating on the stock based on valuation.
News For TEAR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 19, 2015
09:03 EDTTEARCraig-Hallum says its time to buy TearLab
Craig-Hallum believes now is the time to buy TearLab ahead of a growth recovery in 2015, accelerated market adoption of osmolarity as clinical organizations release guidelines, insiders continue to buy, and the management team continues to strengthen. Shares are Buy rated with a $5 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use